$2.49
0.0552.26%
最終更新: Oct 19, 4:00 PM
$2.44
N/A
Benzinga
Benzinga
Benzinga
水曜日, 10 21
Benzinga
© 2026 Benzinga | All Rights Reserved
AC Immune (ACIU) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.20 | $-0.19 | $-0.22 |
| Actual | $0.03 | $-0.19 | $-0.17 | $-0.20 |
| Surprise | +111.4% | +5.00% | +7.89% | +9.09% |
| Revenue | ||||
| Estimate | $1.0M | $1.0M | $2.3M | $1.5M |
| Actual | $19.1M | $1.4M | $422914 | $1.2M |
| Surprise | +1811.8% | +42.9% | -81.6% | -22.8% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.22 | $-0.22 |
| Revenue | ||
| Consensus | $1.0M | $1.0M |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.03 | $-0.22 | 111.4 % |
| Q1 | Apr 30, 2026 | $-0.19 | $-0.20 | 5.00 % |
| Q4 | Mar 13, 2026 | $-0.18 | $-0.19 | 7.89 % |
| Q3 | Nov 4, 2025 | $-0.20 | $-0.22 | 9.09 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $19.12M | $1.00M | 1811.8 % |
| Q1 | Apr 30, 2026 | $1.43M | $1.00M | 42.9 % |
| Q4 | Mar 13, 2026 | $422.91K | $2.30M | -81.6 % |
| Q3 | Nov 4, 2025 | $1.17M | $1.52M | -22.8 % |